Phase II trial of dasatinib in target selected patients with recurrent glioblastoma (RTOG 0627) Meeting Abstract


Authors: Lassman, A. B.; Wang, M. H.; Gilbert, M. R.; Aldape, K. D.; Beumer, J. J.; Wright, J.; Takebe, N.; Puduvalli, V. K.; Hormigo, A.; Gaur, R.; Werner-Wasik, M.; Mehta, M. P.
Abstract Title: Phase II trial of dasatinib in target selected patients with recurrent glioblastoma (RTOG 0627)
Meeting Title: 16th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO) in Conjunction with the AANS/CNS Section on Tumors
Journal Title: Neuro-Oncology
Volume: 13
Issue: Suppl. 3
Meeting Dates: 2011 Nov 17-20
Meeting Location: Orange County, CA
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2011-11-01
Start Page: iii64
Language: English
ACCESSION: WOS:000297026600263
PROVIDER: wos
DOI: 10.1093/neuonc/nor152
PMCID: PMC3199176
Notes: Meeting Abstract: NO-102 -- "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew Lassman
    111 Lassman
  2. Adilia Hormigo
    49 Hormigo